141 related articles for article (PubMed ID: 9219154)
1. ETA receptor blockade prevents hypertension associated with exogenous endothelin-1 but not renal mass reduction in the rat.
Pollock DM; Polakowski JS
J Am Soc Nephrol; 1997 Jul; 8(7):1054-60. PubMed ID: 9219154
[TBL] [Abstract][Full Text] [Related]
2. ETA receptor blockade attenuates the hypertension but not renal dysfunction in DOCA-salt rats.
Allcock GH; Venema RC; Pollock DM
Am J Physiol; 1998 Jul; 275(1):R245-52. PubMed ID: 9688985
[TBL] [Abstract][Full Text] [Related]
3. ETA receptor-mediated responses to endothelin-1 and big endothelin-1 in the rat kidney.
Pollock DM; Opgenorth TJ
Br J Pharmacol; 1994 Mar; 111(3):729-32. PubMed ID: 8019752
[TBL] [Abstract][Full Text] [Related]
4. Endothelin a receptor blockade and endothelin B receptor blockade improve hypokalemic nephropathy by different mechanisms.
Suga S; Yasui N; Yoshihara F; Horio T; Kawano Y; Kangawa K; Johnson RJ
J Am Soc Nephrol; 2003 Feb; 14(2):397-406. PubMed ID: 12538740
[TBL] [Abstract][Full Text] [Related]
5. Role of endothelin ET(A) receptors in the hypertension produced by 4-day L-nitroarginine methyl ester and cyclosporine treatment.
Pollock DM; Polakowski JS; Opgenorth TJ; Pollock JS
Eur J Pharmacol; 1998 Apr; 346(1):43-50. PubMed ID: 9617750
[TBL] [Abstract][Full Text] [Related]
6. Effect of chronic ETA-selective endothelin receptor antagonism on blood pressure in experimental and genetic hypertension in rats.
Schiffrin EL; Turgeon A; Deng LY
Br J Pharmacol; 1997 Jul; 121(5):935-40. PubMed ID: 9222550
[TBL] [Abstract][Full Text] [Related]
7. Endothelin-A receptor antagonism attenuates the hypertension and renal injury in Dahl salt-sensitive rats.
Kassab S; Miller MT; Novak J; Reckelhoff J; Clower B; Granger JP
Hypertension; 1998 Jan; 31(1 Pt 2):397-402. PubMed ID: 9453335
[TBL] [Abstract][Full Text] [Related]
8. Enhanced renal expression of preproendothelin mRNA during chronic angiotensin II hypertension.
Alexander BT; Cockrell KL; Rinewalt AN; Herrington JN; Granger JP
Am J Physiol Regul Integr Comp Physiol; 2001 May; 280(5):R1388-92. PubMed ID: 11294758
[TBL] [Abstract][Full Text] [Related]
9. Beneficial effect of ETA receptor blockade in a rat model of radiocontrast-induced nephropathy.
Pollock DM; Polakowski JS; Wegner CD; Opgenorth TJ
Ren Fail; 1997 Nov; 19(6):753-61. PubMed ID: 9415932
[TBL] [Abstract][Full Text] [Related]
10. Contrasting pharmacological ETB receptor blockade with genetic ETB deficiency in renal responses to big ET-1.
Pollock DM
Physiol Genomics; 2001 Jun; 6(1):39-43. PubMed ID: 11395545
[TBL] [Abstract][Full Text] [Related]
11. Addition of ET(A) receptor blockade increases renoprotection provided by renin-angiotensin system blockade in 5/6 nephrectomized Ren-2 transgenic rats.
Čertíková Chábová V; Vernerová Z; Kujal P; Husková Z; Škaroupková P; Tesař V; Kramer HJ; Kompanowska-Jezierska E; Walkowska A; Sadowski J; Červenka L; Vaněčková I
Life Sci; 2014 Nov; 118(2):297-305. PubMed ID: 24373834
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological characterization of YM598, a selective endothelin-A receptor antagonist.
Sudoh K; Yuyama H; Noguchi Y; Fujimori A; Ukai M; Ohtake A; Sato S; Sasamata M; Miyata K
J Cardiovasc Pharmacol; 2004 Nov; 44 Suppl 1():S390-3. PubMed ID: 15838329
[TBL] [Abstract][Full Text] [Related]
13. Renal damage is not improved by blockade of endothelin receptors in primary renin-dependent hypertension.
Rothermund L; Kossmehl P; Neumayer HH; Paul M; Kreutz R
J Hypertens; 2003 Dec; 21(12):2389-97. PubMed ID: 14654760
[TBL] [Abstract][Full Text] [Related]
14. Effects of systemic and renal intramedullary endothelin-1 receptor blockade on tissue NO and intrarenal hemodynamics in normotensive and hypertensive rats.
Bądzyńska B; Vaneckova I; Sadowski J; Hojná S; Kompanowska-Jezierska E
Eur J Pharmacol; 2021 Nov; 910():174445. PubMed ID: 34492284
[TBL] [Abstract][Full Text] [Related]
15. Blocking both type A and B endothelin receptors in the kidney attenuates renal injury and prolongs survival in rats with remnant kidney.
Benigni A; Zola C; Corna D; Orisio S; Facchinetti D; Benati L; Remuzzi G
Am J Kidney Dis; 1996 Mar; 27(3):416-23. PubMed ID: 8604712
[TBL] [Abstract][Full Text] [Related]
16. Combined endothelin a blockade and chlorthalidone treatment in a rat model of metabolic syndrome.
Jin C; Jeon Y; Kleven DT; Pollock JS; White JJ; Pollock DM
J Pharmacol Exp Ther; 2014 Nov; 351(2):467-73. PubMed ID: 25189702
[TBL] [Abstract][Full Text] [Related]
17. A role for endothelin ETA receptors in regulation of renal function in spontaneously hypertensive rats.
Bird JE; Webb ML; Giancarli MR; Chao C; Dorso CR; Asaad MM
Eur J Pharmacol; 1995 Dec; 294(1):183-9. PubMed ID: 8788430
[TBL] [Abstract][Full Text] [Related]
18. Different contributions of endothelin-A and endothelin-B receptors in the pathogenesis of deoxycorticosterone acetate-salt-induced hypertension in rats.
Matsumura Y; Hashimoto N; Taira S; Kuro T; Kitano R; Ohkita M; Opgenorth TJ; Takaoka M
Hypertension; 1999 Feb; 33(2):759-65. PubMed ID: 10024341
[TBL] [Abstract][Full Text] [Related]
19. Role of the endothelin system in secondary pulmonary hypertension related to air embolism: lessons learned from testing four classes of endothelin blockers in a rat model.
Battistini B; Verreault M; Ayach B; Blouin A; Cernacek P; Jeng AY; Wessale J; Opgenorth T; Tsang J
J Cardiovasc Pharmacol; 2004 Nov; 44 Suppl 1():S386-9. PubMed ID: 15838327
[TBL] [Abstract][Full Text] [Related]
20. ETA receptor-mediated role of endothelin in the kidney of DOCA-salt hypertensive rats.
Fujita K; Matsumura Y; Miyazaki Y; Hashimoto N; Takaoka M; Morimoto S
Life Sci; 1996; 58(1):PL1-7. PubMed ID: 8628104
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
